Anticoagulation in patients with acute ischemic stroke and atrial fibrillation - A balance of risks and benefits

Cardiovascular Drugs and Therapy

Volumn 22, Issue 5, 2008, Pages 419-425

  Beri, Abhimanyu ^a   Punnam, Sujeeth Reddy ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Acute stroke; Anticoagulation; Atrial fibrillation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; THROMBIN INHIBITOR; TINZAPARIN; WARFARIN; XIMELAGATRAN;

ANTICOAGULATION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE PREDISPOSITION; EMBOLISM; HEART ATRIUM FIBRILLATION; HUMAN; MEDLINE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; THERAPY DELAY; THROMBOGENESIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; HUMANS; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 51349119527     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-008-6122-y     Document Type: Review

References (56)

1. DM Lloyd-Jones TJ Wang EP Leip 2004 Lifetime risk for development of atrial fibrillation: the Framingham heart study Circulation 110 1042 6
2. Freestone B, Lip GYH. Epidemiology and costs of cardiac arrhythmias. In: Lip GYH, Godtfredsen J, editors. Cardiac arrhythmias: a clinical approach. Edinburgh: Mosby; 2003. p. 3-24.
3. J Heeringa DA van der Kuip A Hofman 2006 Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur Heart J 27 949 53
4. AD Krahn J Manfreda RB Tate 1995 The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-up Study Am J Med 98 476
5. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. American Heart Association. Heart and Stroke Statistics-2006 Update. Circulation. 2006;113:e85-151. published corrections appears in Circulation. 2006;113:e696 and Circulation. 2006;114:e630. doi: 10.1161/CIRCULATIONAHA.105.171600.
6. VL Feigin CM Lawes DA Bennett CS Anderson 2003 Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century Lancet Neurol 2 43 53
7. J Bogousslavsky C Cachin F Regli 1991 Cardiac sources of embolism and cerebral infarction-clinical consequences and vascular concomitants: the Lausanne Stroke Registry Neurology 41 855 9
8. DC Anderson LJ Kappelle M Eliasziw 2002 Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis Stroke 33 1963
9. MJ Harrison J Marshall 1984 Atrial fibrillation, TIAs and completed strokes Stroke 15 441
10. M Fukuchi J Watanabe K Kumagai 2001 Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage J Am Coll Cardiol 37 1436
11. DG Ritchie BA Levy MA Adams GM Fuller 1982 Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway Proc Natl Acad Sci USA 79 1530
12. F Marin V Roldan V Climent 2003 Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1? Stroke 34 1181
13. M Zabalgoitia JL Halperin LA Pearce 1998 Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation J Am Coll Cardiol 31 1622
14. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography. Ann Intern Med. 1998;128:639. doi: 10.1001/archinte.128.4.639.
15. P Bernhardt H Schmidt C Hammerstingl 2005 Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging J Am Coll Cardiol 45 1807
16. U Dirnagl C Iadecola MA Moskowitz 1999 Pathobiology of ischaemic stroke: an integrated view Trends Neurosci 22 391 7
17. GF Hamann GJ del Zoppo R von Kummer 1999 Hemorrhagic transformation of cerebral infarction-possible mechanisms Thromb Haemost 82 92 4
18. GF Hamann Y Okada GJ del Zoppo 1996 Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion J Cereb Blood Flow Metab 16 1373 8
19. YH Fan L Zhang WWM Lam VCT Mok KS Wong 2003 Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke Stroke 34 2459 62
20. AS Go EM Hylek Y Chang 2003 Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 2685
21. L Frost G Engholm S Johnsen 2000 Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation Am J Med 108 36
22. PA Wolf D RB Agostino AJ Belanger WB Kannwl 1991 Probability of stroke: a risk profile from the Framingham Study Stroke 22 312 8
23. PA Wolf TR Dawber HE Thomas Jr WB Kannel 1978 Epidemiological assessment of chronic atrial fibrillation and the risk of stroke: the Framingham Study Neurology 28 973 7
24. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators 1990 The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 323 1505
25. RG Hart LA Pearce RM Rothbart 2000 Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators J Am Coll Cardiol 35 183
26. GC Flaker K Belew K Beckman AFFIRM Investigators 2005 Asymptomatic atrial fibrillation: demographic features and prognostic information from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study Am Heart J 149 657 63
27. CW Israel G Gronefeld JR Ehrlich 2004 Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. Implications for optimal patient care J Am Coll Cardiol 43 47
28. RL Page WE Wilkinson WK Clair 1994 Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia Circulation 89 224
29. MD Ezekowitz KE James SM Nazarian 1995 Silent cerebral infarction in patients with non-rheumatic atrial fibrillation Circulation 92 2178
30. PA Kempster RP Gerraty PC Gates 1988 Asymptomatic cerebral infarction in patients with chronic atrial fibrillation Stroke 19 955
31. M Cullinane WR Brown 1998 Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: A prospective study Stroke 29 1810
32. GY Lip HS Lim 2007 Atrial fibrillation and stroke prevention Lancet 6 981
33. MC Fang AS Go Y Chang 2008 Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 810 5
34. BF Gage AD Waterman W Shannon 2001 Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2864
35. RG Hart BM Coull D Hart 1983 Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study Stroke 14 688 93
36. RE Kelley JR Berger M Alter AG Kovacs 1984 Cerebral ischemia and atrial fibrillation: prospective study Neurology 34 1285 91
37. CM Fisher RD Adams 1951 Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction J Neuropathol Exp Neurol 10 92 3
38. L Jörgensen A Torvik 1969 Ischaemic cerebrovascular disease in an autopsy series, part 2: prevalence, location, pathogenesis and clinical course of cerebral infarcts J Neurol Sci 9 285 320
39. J Lodder B Krijne-Kubat J Broekman 1986 Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death Stroke 17 626 9
40. A Jaillard C Cornu A Durieux T Moulin F Boutitie KR Lees 1999 Hemorrhagic transformation in acute ischemic stroke. The MAST-E study Stroke 30 1326 32
41. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med. 1998;158:1316. doi: 10.1001/archinte.158.12.1316.
42. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;8(9):651-745. doi: 10.1093/europace/eul097.
43. Cerebral Embolism Study Group (CESG) 1983 Immediate anticoagulation of embolic stroke: a randomized trial Stroke 14 668 76
44. E Berge M Abdelnoor PH Nakstad PM Sandset HAEST Study Group 2000 Low molecular-weight heparin versus aspirin in patients with acute ischemic stroke and atrial fibrillation. A double blind randomized study Lancet 355 1205 10
45. PM Bath E Lindenstrom G Boysen P De Deyn P Friis D Leys 2001 Tinzaparin in acute ischemic stroke (TAIST): a randomized aspirin-controlled trial Lancet 358 702 10
46. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators 1998 Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators JAMA 279 1265 72
47. M Paciaroni G Agnelli S Micheli V Caso 2007 Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke. A meta-analysis of randomized controlled trials Stroke 38 423 30
48. M Camerlingo P Salvi G Belloni T Gamba BM Cesana A Mamoli 2005 Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions Stroke 36 2415 242
49. The International Stroke Trial (IST) 1997 A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. International Stroke Trial Collaborative Group Lancet 349 1569
50. R Saxena S Lewis E Berge 2001 Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial Stroke 32 2333
51. G Gubitz SP Counsell 2004 Anticoagulants for acute ischaemic stroke Cochrane Database Syst Rev 3 CD000024
52. V Gurewich 2005 Ximelagatran-promises and concerns JAMA 293 736 9
53. GW Albers HC Diener L Frison 2005 Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial JAMA 293 690
54. CAST 1997 Randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group Lancet 349 1641
55. RG Hart S Palacio LA Pearce 2002 Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials Stroke 33 2722
56. J Bogousslavsky G Van Melle F Regli 1990 Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: the Lausanne Stroke Registry Neurology 40 1046 50